Towards Healthcare
North America Biotechnology Market to Surge USD 1813.13 Bn by 2034

North America Biotechnology Market Sees Rapid AI-Driven Growth

Market insights predict the global North America biotechnology industry will increase from USD 635.89 billion in 2024 to USD 1813.13 billion by 2034, achieving a CAGR of 11.80%. The increasing adoption of advanced technologies and rising investments bolster market growth. The United States dominated due to the strong presence of key players and favorable regulatory policies.

Content

  • Insight Code: 6286
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The North America biotechnology market in 2025 is valued at USD 706.66 billion and is projected to climb to USD 1813.13 billion by 2034, with a CAGR of 11.80% over the forecast period.

The U.S. is leading the North America biotechnology market due to the availability of state-of-the-art research and development facilities and technological advancements.

Some key players include Thermo Fisher Scientific, Biogen, Inc., and Regeneron Pharmaceuticals.

Biotechnology provides breakthrough products and techniques to combat debilitating diseases, reduce environmental footprint, and use more efficient industrial manufacturing processes.

Food and Drug Administration, National Science Foundation, Government of Canada, Department of Health and Human Services
Any Questions